Category: Latest News
-
HPE shares fall as analysts flag slower growth outlook
Hewlett Packard Enterprise (NYSE:HPE) shares dropped more than 3% on Monday after analysts raised concerns about the company’s near-term growth trajectory. Raymond James downgraded the stock from “Strong Buy” to “Outperform,” citing softer growth expectations while maintaining a constructive long-term view. The firm said the move reflects “less certainty around growth and catalysts,” even as…
-
Eli Lilly reports positive Phase 3 results for Jaypirca in blood cancer study
Eli Lilly and Company (NYSE:LLY) said its therapy Jaypirca achieved the primary endpoint in a Phase 3 trial involving patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The BRUIN CLL-322 study evaluated Jaypirca in combination with venetoclax and rituximab against a regimen of venetoclax and rituximab alone in 639 patients…
-
Best Buy shares slide after Goldman Sachs cuts rating to Sell
Best Buy (NYSE:BBY) shares dropped 4% on Monday after Goldman Sachs Group downgraded the stock from Neutral to Sell and set a price target of $59. The downgrade reflects concerns about potential challenges beyond the first quarter, despite short-term support from stronger PC demand and higher consumer tax refunds. Analyst Kate McShane warned that rising…
-
Halliburton secures multibillion-dollar fracking deal with YPF in Argentina
Halliburton Company (NYSE:HAL) has been awarded a multibillion-dollar contract by YPF to deliver unconventional well completion services in Argentina’s Vaca Muerta shale basin. The multi-year agreement establishes an exclusive partnership covering bundled completion services in Vaca Muerta, widely regarded as one of the largest shale resources outside North America. The contract follows a competitive tender…
-
Goldman Sachs slips despite first-quarter earnings beat
Goldman Sachs Group (NYSE:GS) reported stronger-than-expected first-quarter results, but its shares dropped 3.8% following the announcement. The bank posted earnings per share of $17.55 for the period ending March 31, comfortably ahead of the $16.47 consensus forecast. Revenue came in at $17.23 billion, also topping estimates of $16.95 billion and rising 14% from $15.09 billion…
-
Commvault appoints Gary Merrill as CFO, Geoff Haydon to lead customer operations
Commvault (NASDAQ:CVLT) has announced two senior leadership changes effective immediately, naming Gary Merrill as Chief Financial Officer and Geoff Haydon as President of Customer and Field Operations. Both will report directly to CEO Sanjay Mirchandani. Merrill returns to the CFO position, a role he previously held from 2022 to 2024. Over the past two years,…
-
Allogene shares jump on encouraging ALPHA3 trial update
Allogene Therapeutics (NASDAQ:ALLO) surged 36% on Monday after releasing positive interim data from its pivotal ALPHA3 study, showing that cemacabtagene ansegedleucel (cema-cel) delivered significantly higher minimal residual disease (MRD) clearance rates compared with observation. The interim futility analysis revealed MRD clearance of 58.3% in the cema-cel arm versus 16.7% in the observation group, representing a…
-
Strategy adds nearly 14,000 bitcoin after $1bn preferred stock sale
Strategy Inc (NASDAQ:MSTR) raised $1.00 billion through the sale of 10.03 million shares of its Variable Rate Series A Perpetual Stretch Preferred Stock between April 6 and April 12, 2026, according to a regulatory filing. The company reported net proceeds of $1.00 billion from the transaction, with $21.64 billion still available under its at-the-market (ATM)…
-
Spyre Therapeutics shares jump after positive ulcerative colitis trial data
Spyre Therapeutics (NASDAQ:SYRE) shares climbed 25% on Monday after the company reported that its investigational therapy SPY001 achieved its primary endpoint in a Phase 2 study targeting ulcerative colitis. The biotech group released 12-week results from Part A of its SKYLINE trial, showing that SPY001 delivered a statistically significant 9.2-point reduction in the Robarts Histopathology…
-
3D Systems unveils new dual-laser printer and factory software at RAPID + TCT
3D Systems Corporation (NYSE:DDD) introduced its latest SLA 825 Dual stereolithography system alongside the AddiTrak software platform at the RAPID + TCT 2026 event in Boston. The SLA 825 Dual offers a 22% increase in build volume and delivers up to 25% faster production speeds compared to earlier models. It is aimed at high-throughput manufacturing…